PEPTINOVO BIOPHARMA INC. — Form D/A
PEPTINOVO BIOPHARMA INC. of ANN ARBOR, MI, a company, filed a Form D amendment with the SEC on 2024-12-16. The offering totals $10.0M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-12-16
- Form: D/A
- Accession: 0001868564-24-000002
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $10.0M
- Amount sold: $1.3M
- Remaining: $8.7M
- Investors: 12
- Date of first sale: 2024-09-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-524776
Issuer
- Name: PEPTINOVO BIOPHARMA INC.
- CIK: 0001868564
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 600 S. WAGNER ROAD, ANN ARBOR, MI, 48103
- Phone: 734-330-0265
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| FRED BROWN | Director | ANN ARBOR, MI |
| REYNOLD HOMAN | Director | ANN ARBOR, MI |
| DAVID ROMENESCO | Director | ANN ARBOR, MI |
| STEVE TOKAZ | Director | ANN ARBOR, MI |
| Bill Elliott | Executive Officer | Richmond, VA |
| REYNOLD HOMAN | Executive Officer | ANN ARBOR, MI |
| STEVE TOKAZ | Executive Officer | ANN ARBOR, MI |
Other filings by this issuer (2)
More